RoosterBio Inc. Becomes Industry Partner in NSF-Funded Public-Private Cell Manufacturing Technologies Initiative
FREDERICK, MD. (PRWEB) JUNE 13, 2018 ...
Announcing the Inova Translational Research Funding Program (ITRF)
Inova Health System, through the Office of Research and Commercialization, is excited to share with you the launch of a new research funding initiative, the Inova Translational Research Funding Program (ITRF). This program, which will fund cutting-edge translational research across our system, was created to encourage the development of research talent at Inova and to foster interdepartmental, interinstitutional, academic and industry collaborations. We hope that these partnerships will lead to larger research endeavors that advance our mission to help our patients and our community. ...
National Bioscience Industry Report Shows $2T Economic Impact, Accelerated Venture Capital Investment & Job Growth
Boston, MA (June 5, 2018) – A study released today at the BIO International Convention shows that the U.S. bioscience industry has reached $2 trillion in annual economic impact while maintaining accelerated venture capital investment and job growth numbers. Among U.S. technology sectors, the bioscience industry has held a leading position as an economic driver and job generator. ...
Maryland HIMSS Chapter ANNOUNCES ANNUAL HEALTH IT SCHOLARSHIP PROGRAM
Baltimore, Maryland (June, 2018)- The Maryland HIMSS Chapter is pleased to announce the opening of their annual call for applications of their Health IT scholarships. Every year, Maryland HIMSS awards two deserving students actively enrolled in a health care information technology and/or computer science related degree program. ...
Sirnaomics Closed Series C1 Financing of US$25 Million and Expands Clinical Programs of Anti-Fibrosis and Anti-Cancer RNAi Therapeutics
GAITHERSBURG, MD, June 6, 2018— Sirnaomics, Inc. (www.sirnaomics.com), a leading biopharmaceutical company in development of RNAi therapeutics, announces today that it has closed Series C1 financing of US$25 Million (RMB￥160 Million). This round of financing was led by Yuexiu New Industrial Investment, followed by Sangel Biomedical Venture Capital, HuaKong Equity Investment and Qianhai Shenghui Investment. The proceeds will be used to expand the clinical programs of the lead anti-fibrosis and anti-cancer RNAi therapeutics, strengthen the management team to support growth ...
John Shetrone, Jr. of Vision Named CEO of the Year by Maryland Tech Council
GLEN BURNIE, MD, May 18, 2018 – Vision Technologies, Inc. (Vision), a leading systems integrator, is proud to announce that President and CEO John Shetrone, Jr. was named Chief Executive Officer of the Year by the Maryland Tech Council (MTC) at its 30th Industry Awards Celebration. Vision was also a finalist in the Technology Company of the Year award category. ...
Novavax Promotes John J. Trizzino to Expanded Role as Chief Business Officer and Chief Financial Officer
Gaithersburg, MD, March 14, 2018 – Novavax, Inc., (Nasdaq: NVAX) today announced the promotion of John J. Trizzino to Senior Vice President, Chief Business Officer (CBO) and Chief Financial Officer (CFO). Mr. Trizzino has been serving as Senior Vice President, Commercial Operations, since 2014. As CBO at Novavax, he is now responsible for all pre-commercial and commercial launch strategy and execution as well as public relations. As CFO, he is now responsible for financial reporting, corporate funding, and investor relations. ...
Vision Technologies Launches Corporate Rebranding and New Logo
GLEN BURNIE, MD, May 8, 2018 – Vision Technologies, Inc. (Vision), a leading systems integrator, announces the unveiling of a new corporate brand and logo. The company has kept the same logo since its inception in 2000 and its rebranding represents the successful transition from past to present. ...
GRSi Receives CEO Report’s 2018 Velocity Growth Award
GRSi has been named a winner of the 2018 Velocity Growth Award from CEO Report, their most prestigious award honoring the region’s fastest growing companies for their “determination, dedication and drive [putting] their organizations on the path to continued success that will impact the regional economic landscape for years to come and serve as an example to others.” GRSi President and CEO David Affeldt will accept the award on behalf of the organization at a gala to be held April 19 in Baltimore. ...
Akonni Biosystems Announces Strategic Partnership with Major Chinese Diagnostics Company Righton
Akonni Biosystems Inc. and Chinese in vitro diagnostics company, Righton, announce a commercial agreement that enables Righton to sell Akonni’s products for nucleic acid purification and molecular diagnostics to researchers, clinical laboratories, and hospitals in China. The products to be sold include TruTip®, Akonni’s best-in-class sample preparation technology, which is low-cost and simple, yet highly effective at purifying DNA and RNA from the most difficult sample types. ...